Second probe details more CDC anthrax lab problems

July 14, 2014 by Mike Stobbe

A second investigation found more safety problems at federal health laboratories in Atlanta, including the use of expired disinfectants and the transfer of dangerous germs in Ziploc bags.

The new report focuses on an incident last month at a bioterrorism lab at the Centers for Disease Control and Prevention. Dozens of CDC workers were potentially exposed to dangerous anthrax bacteria. No one got sick, but a CDC internal investigation report released last week found serious safety lapses.

On Monday, a congressional committee released summary of a U.S. Department of Agriculture report on the CDC anthrax incident.

Among the findings: Some potentially exposed CDC lab workers were not examined for five days. Anthrax was not securely stored. And expired disinfectants may have been used in the clean-up.

Explore further: US probes lab workers' possible anthrax exposure (Update)

Related Stories

US probes lab workers' possible anthrax exposure (Update)

June 19, 2014

Some workers at the U.S. Centers for Disease Control and Prevention may have been accidentally exposed to dangerous anthrax bacteria this month because of a safety problem at some of its labs in Atlanta, the federal agency ...

Dozens of US workers taking anti-anthrax drugs

June 20, 2014

The U.S. Centers for Disease Control and Prevention says at least 52 workers are taking antibiotics as a precaution because of a lab safety problem that may have accidentally exposed them to anthrax.

US govt lab mixed up potent flu strain

July 11, 2014

A US government laboratory mistakenly mixed a common flu strain with a dangerous and deadly type of bird flu and shipped it to another lab, authorities said Friday.

CDC issues tough report on anthrax scare

July 12, 2014

(HealthDay)—U.S. health officials have concluded that it's highly unlikely any lab workers were exposed to live anthrax during a safety mishap last month.

Recommended for you

Ebola virus mutations may help it evade drug treatment

September 11, 2015

Genetic mutations called "escape variants" in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according to a team of U.S. Army scientists and collaborators. Their findings, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.